Mark Hatherill1, Shamiel Salie2, Zainab Waggie2, John Lawrenson2, John Hewitson2, Louis Reynolds2, Andrew Argent2. 1. Division of Critical Care and Children's Heart Disease, School of Child and Adolescent Health, University of Cape Town, Cape Town, South Africa. mark.hatherill@uct.ac.za. 2. Division of Critical Care and Children's Heart Disease, School of Child and Adolescent Health, University of Cape Town, Cape Town, South Africa.
Abstract
OBJECTIVE: To explore the relationship between lactate:pyruvate ratio, hyperlactataemia, metabolic acidosis, and morbidity. DESIGN AND SETTING: Prospective observational study in the paediatric intensive care unit (PICU) of a university hospital. PATIENTS: Ninety-seven children after open cardiac surgery. Most children (94%) fell into low-moderate operative risk categories; observed PICU mortality was 1%. INTERVENTIONS: Blood was sampled on admission for acid-base analysis, lactate, and pyruvate. Metabolic acidosis was defined as standard bicarbonate lower than 22 mmol/l, raised lactate as higher than 2 mmol/l, and raised lactate:pyruvate ratio as higher than 20. MEASUREMENTS AND RESULTS: Median cardiopulmonary bypass and aortic cross-clamp times were 80 and 46 min. Metabolic acidosis occurred in 74%, hyperlactataemia in 42%, and raised lactate:pyruvate ratio in 45% of children. In multivariate analysis lactate:pyruvate ratio increased by 6.4 in children receiving epinephrine infusion and by 0.4 per 10 min of aortic cross-clamp. Duration of inotropic support increased by 0.29 days, ventilatory support by 0.27 days, and PICU stay by 0.42 days, for each 1 mmol/l increase in lactate. Neither standard bicarbonate nor lactate:pyruvate ratio were independently associated with prolongation of PICU support. CONCLUSIONS: Elevated lactate:pyruvate ratio was common in children with mild metabolic acidosis and low PICU mortality. Hyperlactataemia, but not elevated lactate:pyruvate ratio or metabolic acidosis, was associated with prolongation of PICU support. Routine measurement of lactate:pyruvate ratio is not warranted for children in low-moderate operative risk categories.
OBJECTIVE: To explore the relationship between lactate:pyruvate ratio, hyperlactataemia, metabolic acidosis, and morbidity. DESIGN AND SETTING: Prospective observational study in the paediatric intensive care unit (PICU) of a university hospital. PATIENTS: Ninety-seven children after open cardiac surgery. Most children (94%) fell into low-moderate operative risk categories; observed PICU mortality was 1%. INTERVENTIONS: Blood was sampled on admission for acid-base analysis, lactate, and pyruvate. Metabolic acidosis was defined as standard bicarbonate lower than 22 mmol/l, raised lactate as higher than 2 mmol/l, and raised lactate:pyruvate ratio as higher than 20. MEASUREMENTS AND RESULTS: Median cardiopulmonary bypass and aortic cross-clamp times were 80 and 46 min. Metabolic acidosis occurred in 74%, hyperlactataemia in 42%, and raised lactate:pyruvate ratio in 45% of children. In multivariate analysis lactate:pyruvate ratio increased by 6.4 in children receiving epinephrine infusion and by 0.4 per 10 min of aortic cross-clamp. Duration of inotropic support increased by 0.29 days, ventilatory support by 0.27 days, and PICU stay by 0.42 days, for each 1 mmol/l increase in lactate. Neither standard bicarbonate nor lactate:pyruvate ratio were independently associated with prolongation of PICU support. CONCLUSIONS: Elevated lactate:pyruvate ratio was common in children with mild metabolic acidosis and low PICU mortality. Hyperlactataemia, but not elevated lactate:pyruvate ratio or metabolic acidosis, was associated with prolongation of PICU support. Routine measurement of lactate:pyruvate ratio is not warranted for children in low-moderate operative risk categories.
Authors: Anthony F Rossi; Danyal M Khan; Robert Hannan; Juan Bolivar; Michel Zaidenweber; Redmond Burke Journal: Intensive Care Med Date: 2004-12-01 Impact factor: 17.440
Authors: M Hatherill; T Sajjanhar; S M Tibby; M P Champion; D Anderson; M J Marsh; I A Murdoch Journal: Arch Dis Child Date: 1997-09 Impact factor: 3.791
Authors: Andrew Durward; Shane M Tibby; Sophie Skellett; Conal Austin; David Anderson; Ian A Murdoch Journal: Pediatr Crit Care Med Date: 2005-05 Impact factor: 3.624
Authors: B Levy; P E Bollaert; C Charpentier; L Nace; G Audibert; P Bauer; P Nabet; A Larcan Journal: Intensive Care Med Date: 1997-03 Impact factor: 17.440
Authors: Massimo Antonelli; Elie Azoulay; Marc Bonten; Jean Chastre; Giuseppe Citerio; Giorgio Conti; Daniel De Backer; François Lemaire; Herwig Gerlach; Johan Groeneveld; Goran Hedenstierna; Duncan Macrae; Jordi Mancebo; Salvatore M Maggiore; Alexandre Mebazaa; Philipp Metnitz; Jerôme Pugin; Jan Wernerman; Haibo Zhang Journal: Intensive Care Med Date: 2008-02-29 Impact factor: 17.440
Authors: Suzanne Perz; Thomas Uhlig; Matthias Kohl; Donald L Bredle; Konrad Reinhart; Michael Bauer; Andreas Kortgen Journal: Intensive Care Med Date: 2010-08-06 Impact factor: 17.440
Authors: Alina G Liedtke; Sebastiano A G Lava; Gregorio P Milani; Carlo Agostoni; Viola Gilardi; Mario G Bianchetti; Giorgio Treglia; Pietro B Faré Journal: J Clin Med Date: 2019-12-27 Impact factor: 4.241